Live Surgery Panel Discussion Multiport: 500,000 Prostates and Counting Why Single Port BioChemical Recurrence Post RARP: 1/3 Are “Benign” (and Don’t Need Treatment) Treating Metastatic Prostate Cancer with Surgery: The SIMCAP Trial PSMA-PET: Changing Practice in Prostate Cancer Diagnosis and Treatment Extended vs. Standard Node Dissection Is the Toxicity of Salvage Prostatectomy Related to the Primary Prostate Cancer Therapy Received? Paul Cathcart, MD Difficult Scenarios during Retzius Sparing Prostatectomy Keith Kowalczyk, MD Prostatectomy Surprises and Tips for Handling Them SP in Obese PatientsSchedule
Saturday 10 July, 2021
Live Surgery: Extraperitoneal Single Port Prostatectomy
Jean Joseph, MD, MBA
All PanelistsSingle Port vs. Multiport Prostatectomy
Jonathan Henderson, MD
Matt Tollefson, MDRARP for High Risk Disease/How to Improve Oncologic Outcomes
Tom Ahlering, MD
Isaac Kim, MD, PhD, MBA
A/Prof Daniel Moon
Alvin Goh, MDPanel Discussion-Challenging Scenarios in SP and Multiport RARP
Kirsten Greene, MD
John Davis, MD, FACS